BSX:NYSE
Boston Scientific Corp
$44.41
arrow_upward
+1.23%(+0.54) 1D
Sep 16, 9:45:36 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSX...
Open
$43.85
High
$44.30
Low
$43.65
Mkt. cap
64.17B
Avg. vol.
19.50M
Volume
426.64K
P/E ratio
17.96
52-wk high
$105.65
52-wk low
$42.20
EPS
$2.47
Beta
0.57
Shares outstanding
1.45B
No. of employees
59K
Open
$43.85
High
$44.30
Low
$43.65
Mkt. cap
64.17B
Avg. vol.
19.50M
Volume
426.64K
P/E ratio
17.96
52-wk high
$105.65
52-wk low
$42.20
EPS
$2.47
Beta
0.57
Shares outstanding
1.45B
No. of employees
59K
News stories
From web sources and news partners
GuruFocus
·
2 hours ago
Is BSX Undervalued? DCF Says Worth $53
Kalkine Media
·
5 hours ago
What Has Put Boston Scientific (BSX) Back in Focus?
Zacks
·
5 hours ago
New Strong Sell Stocks for September 16th
Yahoo Finance
·
5 hours ago
New Strong Sell Stocks for September 16th
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com